Reading the adjunct evidence the way a reviewer would The pivotal liraglutide trials, ADJUNCT ONE and TWO, showed HbA1c effects below the regulatory threshold alongside dose-related ketosis and symptomatic hypoglycaemia, and the FDA did not approve liraglutide for type 1 on efficacy and safety grounds.6 The newer story is the automated-insulin-delivery era: ADJUST-T1D paired weekly semaglutide with an AID system in 72 adults with type 1 and obesity, and a composite goal (time in range above 70%, time below range under 4%, and at least 5% weight loss) was met by 36% versus 0% on placebo, with no ketoacidosis.8 Tirzepatide in type 1 rests on a single-centre observational cohort of 26 with no control arm
What to Watch For Standard Commercial Plans Wegovy's preferred status from July 2025 is expected to continue
Some podiatrists are calling the adverse reaction Ozempic feet. Thats because when people lose a lot of weight quickly, their feet also lose fat
Lemonade made with real lemon juice, or citrate supplements prescribed by your provider, can reduce stone risk by 30% to 50%
Aims to control appetite and improve blood sugar levels
